Analyst Price Targets — OMDA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 16, 2026 12:00 pm | David Roman | Goldman Sachs | $26.00 | $15.65 | TheFly | Omada Health price target lowered to $26 from $29 at Goldman Sachs |
| January 9, 2026 10:52 am | — | Goldman Sachs | $29.00 | $16.44 | TheFly | Omada Health price target lowered to $29 from $33 at Goldman Sachs |
| January 8, 2026 9:19 pm | — | Wells Fargo | $17.00 | $16.44 | TheFly | Omada Health initiated with an Equal Weight at Wells Fargo |
| January 5, 2026 11:46 am | Saket Kalia | Barclays | $22.00 | $14.90 | TheFly | Omada Health price target lowered to $22 from $29 at Barclays |
| December 18, 2025 12:58 pm | — | Morgan Stanley | $32.00 | $14.62 | TheFly | Omada Health named Top Pick in Healthcare Technology at Morgan Stanley |
| October 8, 2025 12:16 pm | Elizabeth Anderson | Evercore ISI | $27.00 | $25.00 | TheFly | Omada Health added to 'Tactical Outperform' list at Evercore ISI |
| September 5, 2025 9:46 am | — | Robert W. Baird | $24.00 | $24.28 | TheFly | Omada Health initiated with a Neutral at Baird |
| July 1, 2025 10:39 am | — | Needham | $23.00 | $18.25 | TheFly | Omada Health initiated with a Buy at Needham |
Latest News for OMDA
SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include dedicated cholesterol management alongside weight, glucose, blood pressure, and GLP-1 support. Up to 70% of adults with obesity have high cholesterol,1 yet among U.S. adults with atherosclerotic cardiovascular disease,…
SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its fourth quarter and full year 2025 results on Thursday, March 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details A live audio webcast of the call will be available online at…
Omada Health, Inc. (OMDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending a previous six-month analysis , findings underscore the program's role in helping employers manage the complexity of today's weight loss medication market while…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OMDA.
U.S. House Trading
No House trades found for OMDA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.